Cell therapy startup raises $16 million to fund its quest for the Holy Grail in regenerative medicine

Cell therapy startup raises $16 million to fund its quest for the Holy Grail in regenerative medicine

Source: 
Endpoints
snippet: 

In 2006, Shinya Yamanaka shook stem cell research with his discovery that mature cells can be converted into stem cells, relieving a longstanding political-ethical blockage and throwing open medical research on everything from curbing eye degeneration to organ printing.